Tevogen (TVGN) EPS (Basic) (QoQ) (2022 - 2026)
Tevogen (TVGN) EPS (Basic) (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - |
| 10 | Tevogen | 26.21 Mn | 26.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.42% |
| Mar 31, 2026 | -11.11% |
| Dec 31, 2025 | 2.95% |
| Sep 30, 2025 | 2.29% |
| Jun 30, 2025 | 52.97% |
| Mar 31, 2025 | -1.45% |
| Dec 31, 2024 | -84.74% |
| Sep 30, 2024 | 11.88% |
| Jun 30, 2024 | -151.51% |
| Mar 31, 2024 | -98.34% |
| Dec 31, 2023 | 1,516.18% |
| Sep 30, 2023 | -2,542.32% |
| Jun 30, 2023 | -127.90% |
| Mar 31, 2023 | 753.07% |
| Dec 31, 2022 | -160.34% |
| Sep 30, 2022 | 679.18% |
| Jun 30, 2022 | 365.50% |